KERYX BIOPHARMACEUTICALS INC (KERX) has 179 open-market insider trades by 17 insiders since 2006. The most active filer is James F. Oliviero III, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ron Bentsur | CEO | — | 26 | $12.3M | 2015-04-06 |
| James F. Oliviero III | CFO | — | 33 | $8.5M | 2015-07-06 |
| Michael S. Weiss | 10% | — | 3 | $5.2M | 2010-05-10 |
| Larry Kessel | Dir | — | 1 | $1.3M | 2006-03-08 |
| Greg Madison | CEOPres | — | 24 | $732K | 2018-03-20 |
| Scott A. Holmes | CFO | — | 19 | $287K | 2018-12-12 |
| John F. Neylan | Chief Medical Officer | — | 22 | $267K | 2018-12-12 |
| Brian Adams | Secretary | — | 25 | $262K | 2018-02-15 |
| Jack Kaye | Dir | — | 4 | $255K | 2015-06-17 |
| Michael P. Tarnok | Dir | — | 5 | $199K | 2015-06-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Christine A. Carberry | COO | Sell | $34K | 2018-12-11 |
| Scott A. Holmes | CFO | Sell | $3K | 2018-11-15 |
| John F. Neylan | Chief Medical Officer | Sell | $3K | 2018-11-15 |
| John F. Neylan | Chief Medical Officer | Sell | $4K | 2018-10-29 |
| Scott A. Holmes | CFO | Sell | $4K | 2018-10-29 |
| Christine A. Carberry | COO | Sell | $7K | 2018-10-18 |
Companies that share insiders with KERX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John F. Neylan | Chief Medical Officer | Sell | $4K | 2018-08-15 |
| Scott A. Holmes | CFO | Sell | $4K | 2018-08-15 |
| John F. Neylan | Chief Medical Officer | Sell | $5K | 2018-07-30 |
| Scott A. Holmes | CFO | Sell | $9K | 2018-07-30 |
| Christine A. Carberry | COO | Sell | $9K | 2018-07-18 |
| Kevin J. Cameron | Director | Sell | $8K | 2018-06-18 |
| Steven C. Gilman | Director | Sell | $7K | 2018-06-11 |
| Kevin J. Cameron | Director | Sell | $9K | 2018-05-29 |
| Steven C. Gilman | Director | Sell | $7K | 2018-05-29 |